1. |
2009/11/03 |
Does transection of the spermatic cord lower the incidence of inguinal hernia after radical retropubic prostatectomy? (ポスター掲示,一般)
|
2. |
2022/04/16 |
A preliminary report of a prospective study of MRI-ultrasound fusion-guided ultrafocal high-dose rate brachytherapy for localized prostate cancer (口頭,一般)
|
3. |
2020/07 |
90 Anti-inflammatory effect of IDO1 inhibition for acute inflammation in the prostate (ポスター掲示,一般)
|
4. |
2020/07 |
New pathological subtype of renal cell carcinoma in patients on long-term dialysis: acquired cystic disease-associated renal cell carcinoma (一般)
|
5. |
2020/07 |
Pathological analysis focused on inflammatory changes in bladder dysfunction following partial bladder outlet obstruction (ポスター掲示,一般)
|
6. |
2019/12/01 |
Clinical Implementation of MRI-ultrasound Fusion-guided Prostate Biopsy in the Management of Prostate Cancer: What Radiologists Should Know (一般)
|
7. |
2019/11/09 |
Preventive effect of tadalafil for chronic inflammation in the prostate (口頭,一般)
|
8. |
2019/10/19 |
Renal Cell Carcinoma in Japanese Patients with End-Stage Renal Disease (ポスター掲示,一般)
|
9. |
2019/10/19 |
Validation of the Prostate Imaging and Reporting Data System Version 2(PI-RADS v2) for the detection of prostate cancer in Japanese men with elevated PSA Level. (ポスター掲示,一般)
|
10. |
2019/05/10 |
Comparison of Stretched-Exponential, IVIM and Monoexponential Diffusion-Weighted Imaging Mathematical Models for Assessment of Tumor Aggressiveness in Prostate Cancer at 3T (口頭,一般)
|
11. |
2019/04/11 |
The application of color Doppler ultrasonography in patients with ejaculation dysfunction and a male volunteer with the squirting phenomenon after ejaculation: an update (ポスター掲示,一般)
|
12. |
2019/03/17 |
Changes in circulating blood volume measured by pulse dye-densitometry during preoperative management with an α-blocker in patients with pheochromocytoma (ポスター掲示,一般)
|
13. |
2019/03/17 |
Therapeutic effect of tadalafil in the chronic prostatitis (ポスター掲示,一般)
|
14. |
2018/09/23 |
Laparoscopic adrenal-sparing surgery in pheochromocytoma associated with multiple endocrine neoplasia type 2A (口頭,一般)
|
15. |
2018/09/07 |
高PSA血症例に対する前立腺MRI-超音波融合画像ガイド下生検の初期経験 (口頭,一般)
|
16. |
2018/05/18 |
Risk of secondary bladder cancer after high dose rate brachytherapy for prostate cancer (口頭,一般)
|
17. |
2018/04/19 |
The role of indoleamine 2,3-dioxygenase (IDO) in prostatitis (口頭,一般)
|
18. |
2018/04/18 |
The risk of urothelial carcinoma of the bladder in prostate cancer patients treated with high-dose-rate
brachytherapy: a case-control study (ポスター掲示,一般)
|
19. |
2017/10/19 |
Prospective study of a switching GnRH agonist therapy in castration resistant prostate cancer in Japanese patients (ポスター掲示,一般)
|
20. |
2017/05/12 |
Therapeutic effect of indoleamine 2,3-dioxygenase inhibitor in epididymitis (口頭,一般)
|
21. |
2017/05/12 |
Therapeutic effect of RIPK1 inhibitor in testicular ischemia-reperfusion (ポスター掲示,一般)
|
22. |
2017/03/24 |
Therapeutic effect of indoleamine 2,3-dioxygenase inhibitor in epididymitis (ポスター掲示,一般)
|
23. |
2017/03/24 |
Therapeutic effect of RIPK1 inhibitor in testicular ischemia-reperfusion (口頭,一般)
|
24. |
2017/01/14 |
Effects of microscopic subinguinal varicocelectomy on semen analysis findings and fertility of infertile male patients with varicocele (ポスター掲示,一般)
|
25. |
2016/11/11 |
Endoscopic removal of MemothermR using holmium YAG laser:A report of 3 cases (ポスター掲示,一般)
|
26. |
2016/11/11 |
Initial experience with the EMARO pneumatic laparoscopic holder robot in laparoscopic urological surgery
|
27. |
2016/11/11 |
Therapeutic results and complications of ureteroscopic lithotripsy (ポスター掲示,一般)
|
28. |
2016/05/07 |
Tadalafil for male LUTS improves endothelial function (口頭,一般)
|
29. |
2016/05/07 |
The role of indoleamine 2,3-dioxygenase in epididymitis (口頭,一般)
|
30. |
2016/04/02 |
Effects of microscopic subinguinal varicocelectomy on semen analysis findings and fertility of infertile male patients with varicocele (口頭,一般)
|
31. |
2016/04/01 |
Pilot study of penile brachial index for Erectile Dysfunction (口頭,一般)
|
32. |
2016/03/12 |
The role of indoleamine 2,3-dioxygenase in epididymitis (口頭,一般)
|
33. |
2015/02 |
Evaluation of vascular endothelial function for patients with Erectile Dysfunction (ポスター掲示,一般)
|
34. |
2015/02 |
Maintenance of oral administration of anticholinergic drugs for overactive bladder (ポスター掲示,一般)
|
35. |
2014/10/23 |
Change of sexual functions in patients with benign prostatic hyperplasia after holmium laser enucleation of the prostate (HoLEP). (口頭)
|
36. |
2014/09/04 |
Unilateral adrenalectomy followed by contralateral laparoscopic partial adrenalectomy for men 2a: A report of two cases (口頭,一般)
|
37. |
2013/11/07 |
The relationships between salivary testosterone, serum sex hormones and lower urinary tract symptoms, sexual function in patients with benign prostate hyperplasia. (口頭,一般)
|
38. |
2013/11/07 |
Use of PDE5 inhibitors in elderly at Kawasaki medical school. (口頭,一般)
|
39. |
2013/10/24 |
A peritoneal wall anchor technique using a new device for laparoscopy-assisted catheter placement in peritoneal dialysis (口頭,一般)
|
40. |
2013/09/11 |
Spectrum of renal cell carcinoma histological subtypes arising end-stage renal disease. (ポスター掲示,一般)
|
41. |
2013/09/09 |
Change of Urinary, Sexual, and Bowel Function after Holmium Laser Enucleation of the Prostate (HoLEP) for Benign Prostatic Hyperplasia. (ポスター掲示,一般)
|
42. |
2013/09/09 |
The Relationships between Salivary Testosterone, Serum Sex Hormones and Lower Urinary Tract Symptoms, Sexual Function in Patients with Benign Prostate Hyperplasia. (ポスター掲示,一般)
|
43. |
2013/05/07 |
Correlation of urinary oxidant stress marker level with the response of antimuscarinic therapy in patients with female overactive bladder (口頭,一般)
|
44. |
2013/03/16 |
Vasohibin-1 is a novel independent predictor of disease-free survival in curatively operated renal cell carcinoma patients (ポスター掲示,一般)
|
45. |
2013/02/14 |
Change of sexual functions in patients with benign prostatic hyperplasia after holmium laser enucleation of the prostate (HoLEP) (ポスター掲示,一般)
|
46. |
2013/02/14 |
Comparison of transperineal and transrectal 12-core initial prostate biopsy with PSA levels between 4.0 and 20.0 ng/ml (口頭,一般)
|
47. |
2013/02/14 |
Correlation with urothelium and primary symptoms in interstitial cystitis: investigation of scanning electron microscopy (ポスター掲示,一般)
|
48. |
2013/02/14 |
Investigation of histological feature and bladder function in rat insterstitial cystitis model (ポスター掲示,一般)
|
49. |
2012/10/01 |
Long-Term Compliance and Treatment Failure of alpha1-Blocker for Patients with Male Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia. (ポスター掲示,一般)
|
50. |
2012/09/07 |
Incidental Prostate Cancer in Holmium Laser Enucleation of the Prostate (HoLEP) (ポスター掲示,一般)
|
51. |
2012/09/05 |
Prognostic factors in subsequent development of bladder cancer after the surgical management of primary upper urinary tract urothelial carcinoma (ポスター掲示,一般)
|
52. |
2012/08/04 |
Analysis of human ejaculation using color Doppler ultrasonography (口頭,シンポジウム・ワークショップ パネル(その他))
|
53. |
2012/08/04 |
Evaluation of patients with symptoms of male andropause (ポスター掲示,一般)
|
54. |
2012/05/22 |
Improvement of sexual function in patients with benign prostatic hyperplasia treated by holmium laser enucleation of the prostate (HoLEP) (口頭,一般)
|
55. |
2012/05/21 |
Clinical efficacy of a new botulinum toxin type A free of complexing proteins in the treatment of refractory neurogenic and idiopathic detrusor overactivity (ポスター掲示,一般)
|
56. |
2012/05/21 |
Correlation with urinary epithelium and primary symptoms in interstitial cystitis: investigation of scanning electron microscopy (口頭,一般)
|
57. |
2012/04/23 |
Improvement of sexual function in patients with benign prostatic hyperplasia treated by holmium laser enucleation of the prostate (HoLEP) (口頭,一般)
|
58. |
2012/02/04 |
Use of Fuhrman grading system for Japanese patients with renal cell carcinoma (ポスター掲示,一般)
|
59. |
2011/10/29 |
Forty percent of patients with ureteral stones who visit the emergency room first are not followed by urologists. (口頭,一般)
|
60. |
2011/10/29 |
Health-Related Quality of Life in Patients with Localized Prostate Cancer Received High-Dose-Rate Brachytherapy: A Time-Course Analysis. (口頭)
|
61. |
2011/10/29 |
Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after initial treatment. (口頭,一般)
|
62. |
2011/10/19 |
Comparison of Two Different Antimuscarinics, Imidafenacin and Solifenacin for Treatment of Overactive Bladder: A Prospective Randomized Controlled Study (ポスター掲示,一般)
|
63. |
2011/10/19 |
Correlation of Urinary Nerve Growth Factor Level With the Response of Antimuscarinic Therapy in Patients With Overactive Bladder (ポスター掲示,一般)
|
64. |
2011/10/18 |
Correlation with Urinary Epithelium and Primary Symptoms in Interstitial Cystitis: Inbestigation of Scannin Electron Microscopy (ポスター掲示,一般)
|
65. |
2011/10/18 |
Risk Factor Analysis of Patients’Dissatisfaction After Holmium LaserEnucleation of the Prostate (HoLEP)for Benign Prostatic Hyperplasia (ポスター掲示,一般)
|
66. |
2011/10/17 |
Efficacy of Transperineal Versus Transrectal 12-Core Initial Prostate Biopsy with PSA Levels Between 4.0 and 20.0 ng/ml (口頭,一般)
|
67. |
2011/10/17 |
Prognostic Factors and Survival of Renal Cell Carcinoma in Japanese Patients (ポスター掲示,一般)
|
68. |
2011/10/17 |
Retroperitoneal Dedifferentiated Liposarcoma with Production of Granulocyte Colony-Stimulating Factor (G-CSF) Accompanied by Spontaneous Rupture: PET/CT Imaging of a G-CSF-Producting Tumor (ポスター掲示,一般)
|
69. |
2011/09/01 |
Comparison of two different antimuscarinics, Imidafenacine and solifenacin, for treatment of overactive bladder: A prospective randomized controlled study (ポスター掲示,一般)
|
70. |
2011/08/31 |
Correlation of urinary nerve growth factor level with the response of antimuscarinic therapy in patients with overactive bladder (ポスター掲示,一般)
|
71. |
2011/08/31 |
Correlation with urinary epithelium and primary symptoms in interstitial cystitis: investigation of scanning electron microscopy (ポスター掲示,一般)
|
72. |
2010/07/09 |
Function of Prostate in Ejaculation (口頭,シンポジウム・ワークショップ パネル(その他))
|
73. |
2009/11/01 |
The Effects of 3 Types of Alpha1-Adrenoceptor Blockers on Lower Urinary Tract Symptoms and Sexual Functions in Men with Benign Prostatic Hyperplasia
|
74. |
2008/09/20 |
Clinical outcome in patients with locally and locally advanced prostate cancer treated with high-dose-rate brachytherapy. (口頭,一般)
|
75. |
2008/09/20 |
Optimal approach for prostate cancer detection as initial biopsy:A prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. (口頭,一般)
|
76. |
2007/11/17 |
IRIDIUM-192 HIGH-DOSE-RATE BRACHYTHERAPY FOR T1c-T3bN0M0 PROSTATE CANCER (口頭)
|
77. |
2007/09/02 |
IRIDIUM-192 HIGH-DOSE-RATE BRACHYTHERAPY FOR T1c-T3bN0M0 PROSTATE CANCER (口頭,一般)
|
78. |
2007/05/19 |
Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder (ポスター掲示)
|
79. |
2007/05/19 |
Ejaculatory dysfunction caused by new A1-blocker: analysis of human ejaculatory phenomenon using color doppler ultrasonography (口頭)
|
80. |
2006/09/15 |
The experience of using dual lumen ureteral access sheath (AquaGuideTM) in ureteropyeloscopy (一般)
|
Display 5 items
|
Display all(80)
|